Placebo

Phase 2

14%

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

Upcoming Catalysts

Sep 2026~

ITCI⭐Phase 3Phase 2

Placebo Phase 3 Results Expected

Placebo • Psychosis Associated With Alzheimer's Disease

May 2026~

ITCI⭐Phase 3Phase 2

Placebo Phase 3 Results Expected

Placebo • Psychosis Associated With Alzheimer's Disease

Mar 2026~

ITCI⭐Phase 3Phase 2

Placebo Phase 3 Results Expected

Placebo • Psychosis Associated With Alzheimer's Disease

Drug Information

Target Indication

Psychosis Associated With Alzheimer's Disease

Clinical Trial

Last updated: 12/4/2025

Developer

ITCI

Intra-Cellular Therapies, Inc.